Modelo predictivo de ansiedad y depresión en pacientes españoles con enfermedad pulmonar obstructiva crónica estable

González-Gutiérrez, María Victoria; Velázquez, José Guerrero; García, Concepción Morales; Maldonado, Francisco Casas; Jiménez, Francisco; Vargas, Francisco González

doi:10.1016/j.arbres.2015.09.003

Cited by 17 publications

(11 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Our study showed a 38.6% prevalence of depressive symptoms, a little higher than that found in the study by Zhang et al 16 , which identified a 24.6% prevalence of depressive symptoms in patients with COPD compared to the control group, and also found that patients with COPD were 2.8 times more likely to have depressive symptoms. Oliveira and Gonçalves 21 showed that depressive symptoms compromise 10-60% of these individuals, and factors such as smoking, social isolation, use of medications for COPD treatment (corticosteroids, bronchodilators) can cause psychiatric symptoms or intensify problems such as depressive mood, mania, psychosis, delirium, or behavioral changes, which is similar to the findings in our study.…”

Section: Discussionsupporting

confidence: 91%

“…The presence of depressive symptoms can be defined as the existence of depressed mood, and loss of interest or pleasure in activities which can cause damage in social, occupational and functional actions of an individual 21 . Depressive symptoms among patients with COPD are considered the main psychiatric comorbidity of this group, representing the systemic and extra pulmonary disease stage 3,[21][22][23] capable of determining a decrease in functionality, development of activities 24,25 , and quality of life 5 .…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Activities of daily living in patients with chronic obstructive pulmonary disease with depressive symptoms

et al. 2020

View full text Add to dashboard Cite

This cross-sectional study assessed the activities of daily living (ADL) and risk factors for developing depressive symptoms in patients with chronic obstructive pulmonary disease (COPD) and was carried out at the pulmonology outpatient clinic of the Hospital Universitário Oswaldo Cruz. Two hundred two (202) patients with COPD participated in the study. We evaluated the sociodemographic and anthropometric data, the ADL by means of Pulmonary Functional Status and Dyspnea Questionnaire - Modified version (PFSDQ-M), and the presence of depressive symptoms using the Beck Depression Inventory (BDI). All domains (dyspnea, fatigue and activity changes) of PFSDQ are compromised in patients with depressive symptoms. The prevalence of depressive symptoms was 38.6%. The chance of developing these symptoms was higher for those who used more than one bronchodilator (OR: 2.82, CI 95%: 1.47-5.38, p=0.002), presented dyslipidemias (OR: 2.74, CI95%: 1.24-6.07, p=0.012), had a heart disease (OR: 2.82, CI 95%: 1.18-6.74, p=0.020), presented expectoration (OR: 2.44, CI 95%: 1.2-4.95, p=0.014) or did not have a partner (OR: 2.58, CI 95%: 1.36-4.9, p=0.004). COPD patients with depressive symptoms had all domains of ADL compromised compared to patients without these symptoms.

show abstract

Section: Discussionsupporting

confidence: 91%

Section: Discussionmentioning

confidence: 99%

Activities of daily living in patients with chronic obstructive pulmonary disease with depressive symptoms

et al. 2020

View full text Add to dashboard Cite

show abstract

“…It has also been observed that the longer a person with COPD walks per day the lower the probability of suffering from depression [ 24 ]. However, it should be noted that our study did not take into account several relevant clinical determinants such as the BODE index, which has been shown to be closely related to depression in people with COPD [ 25 ].…”

Section: Discussionmentioning

confidence: 99%

Self-reported walking and associated factors in the Spanish population with chronic obstructive pulmonary disease

Benito

Romero

2018

BMC Pulm Med

View full text Add to dashboard Cite

BackgroundThe level of physical activity among individuals with chronic obstructive pulmonary disease (COPD) is associated with the disease severity and prognosis. The aim of this study was to describe the prevalence of self-reported walking at least 150 min per week and the associated factors among the Spanish population with COPD.MethodsAnalyses were based on data drawn from the 2009 European Health Interview Survey in Spain (2009 EHIS). Twenty-two thousand one hundred eighty-eight subjects participated in the survey (response rate of 96.5%). Participants were classified according to international physical activity recommendations. The prevalence of walking among participants with and without COPD (≥40 years old) was described. Univariate and multivariate logistic regression models were used to study the association of walking with socio-demographic and health outcome variables.ResultsOf the participants with COPD, 55.0% reached the minimum walking recommendations compared to 59.9% of the general population. The level of walking physical activity of the participants with COPD differed according to sex, age, educational level, area of residence, living as a couple, self-rated health status, mental health, body mass index and hospital admissions. In the multivariate analysis, being male, < 65 years old, living in an area with ≥50,000 inhabitants, no diagnosed depression or anxiety and self-reported good to very good health were factors significantly associated with walking ≥150 min per week.ConclusionsSex, age, area of residence, mental disorders and self-rated health are associated with weekly walking time in the Spanish population with COPD.

show abstract

“…In our study, the relationship between BODE indices and anxiety scores showed a positive correlation that approached but did not reach statistical significance. In the current medical literature, many studies demonstrated that the BODE index correlated better with anxiety and depression than % of predicted FEV1 [32,33].…”

Section: Discussionmentioning

confidence: 99%

Anxiety and depression in patients with chronic obstructive pulmonary disease and their relation to serum vitamin D levels

Kocakaya¹,

Yıldızeli²,

Kocakaya³

et al. 2018

Marmara Medical Journal

View full text Add to dashboard Cite

Anxiety and depression in patients with chronic obstructive pulmonary disease and their relation to serum vitamin D levels Kronik obstrüktif akciğer hastalığı olan hastalarda anksiyete ve depresyon ile serum D vitamini düzeyleri arasındaki ilişki ABSTRACT Objectives: To determine whether serum vitamin D levels were related to the risk of anxiety and depression among patients with chronic obstructive pulmonary disease (COPD), as well as their spirometry parameters, disease severity, and other clinical findings. Materials and Methods: Ninety-two stable patients with COPD aged over 18 years with no exacerbations in the previous month were included. Symptom severity was assessed using the modified Medical Research Council (mMRC) dyspnea scale and COPD Assessment Test (CAT) scores. Spirometry tests were performed and previous hospitalization histories were recorded to determine ABCD groups of the patients according to their combined COPD assessments. Their Body mass index, airflow Obstruction, Dyspnea and Exercise capacity (BODE) indices were calculated and the Hospital Anxiety and Depression Scale (HADS) was administered. Serum vitamin D levels were determined using immune electrochemiluminescence. Results: According to the HADS scores, 16 patients (17.4%) had the risk of anxiety and 29 (31.5%) had the risk of depression. The risk of anxiety differed significantly (P= 0.016 Fischer's exact test) between the ABCD groups. Anxiety scores were positively correlated with both mMRC (r= 0.315; P= 0.002) and CAT (r= 0.445; P= 0.000) scores. Similarly, depression scores correlated positively with mMRC (r= 0.249; P= 0.017) and CAT (r= 0.373; P= 0.000) scores. Neither anxiety nor depression scores were significantly correlated with % of predicted FEV1. Serum vitamin D levels were inversely correlated with anxiety (r=-0.215; P= 0.039) and depression (r=-0.244; P= 0.019) scores. Anxiety scores were positively correlated with BODE although not statistically significantly (r= 0.199; P= 0.058). Conclusion: A negative correlation was revealed between serum vitamin D levels and HADS scores, and symptom scores were positively correlated to HADS scores, independent of % of predicted FEV1.

show abstract

Modelo predictivo de ansiedad y depresión en pacientes españoles con enfermedad pulmonar obstructiva crónica estable

Cited by 17 publications

References 30 publications

Activities of daily living in patients with chronic obstructive pulmonary disease with depressive symptoms

Activities of daily living in patients with chronic obstructive pulmonary disease with depressive symptoms

Self-reported walking and associated factors in the Spanish population with chronic obstructive pulmonary disease

Anxiety and depression in patients with chronic obstructive pulmonary disease and their relation to serum vitamin D levels

Contact Info

Product

Resources

About